PEAK6 Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-300
Closed -$41.1K 3597
2024
Q2
$41.1K Sell
300
-10,400
-97% -$1.42M ﹤0.01% 3189
2024
Q1
$1.42M Sell
10,700
-20,100
-65% -$2.61M ﹤0.01% 1677
2023
Q4
$4.25M Buy
30,800
+25,800
+516% +$3.39M 0.02% 965
2023
Q3
$609K Buy
5,000
+4,000
+400% +$533K ﹤0.01% 2231
2023
Q2
$141K Sell
1,000
-12,200
-92% -$1.68M ﹤0.01% 3081
2023
Q1
$1.87M Sell
13,200
-24,100
-65% -$3.45M 0.01% 1363
2022
Q4
$5.84M Sell
37,300
-13,000
-26% -$1.87M 0.03% 633
2022
Q3
$6.17M Buy
50,300
+44,700
+798% +$5.89M 0.03% 708
2022
Q2
$753K Sell
5,600
-10,700
-66% -$1.46M ﹤0.01% 3368
2022
Q1
$2.23M Sell
16,300
-39,600
-71% -$5.52M ﹤0.01% 1751
2021
Q4
$9.67M Buy
55,900
+54,600
+4,200% +$8.31M 0.02% 730
2021
Q3
$189K Buy
1,300
+1,200
+1,200% +$176K ﹤0.01% 4032
2021
Q2
$13K Buy
+100
New +$13.1K ﹤0.01% 4785
2020
Q4
Sell
-4,200
Closed -$478K 4674
2020
Q3
$478K Sell
4,200
-20,000
-83% -$2.36M ﹤0.01% 2892
2020
Q2
$2.76M Buy
24,200
+24,100
+24,100% +$2.56M 0.01% 1222
2020
Q1
$8K Hold
100
﹤0.01% 3848
2019
Q4
$11K Sell
100
-6,200
-98% -$647K ﹤0.01% 3213
2019
Q3
$671K Sell
6,300
-400
-6% -$41.1K ﹤0.01% 2052
2019
Q2
$682K Sell
6,700
-51,000
-88% -$4.9M ﹤0.01% 2061
2019
Q1
$5.19M Buy
+57,700
New +$5M 0.03% 685
2018
Q4
Sell
-1,900
Closed -$205K 4157
2018
Q3
$205K Buy
+1,900
New +$208K ﹤0.01% 3208

Other funds holding DGX

PEAK6 Investments's DGX Position: Q3 2024 in Review

PEAK6 Investments sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 2,875 shares — an estimated $429K sold.

PEAK6 Investments first reported a position in DGX in Q3 2018 and held it in 9 quarters. The position peaked at $2.5M in Q3 2022. 846 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • PEAK6 Investments reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2,875 Quest Diagnostics shares in Q3 2024, an estimated $429K.
  • PEAK6 Investments first reported a position in Quest Diagnostics in Q3 2018 and held it in 9 quarters.
  • PEAK6 Investments's Quest Diagnostics position peaked at $2.5M in Q3 2022.
  • 846 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.